Description

The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive

Related Content:

• The US Now Has a Research Plan for Long COVID—Is It Enough?
• Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
• Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
• Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise
• Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change
• Addressing the Long-term Effects of COVID-19
• Long COVID: The US Federal Response (audio)
• Long COVID: The US Federal Response (video)